investordatabase.org

Sanofi Ventures

sanofiventures.com Direct investor

Sanofi Ventures is the corporate venture capital arm of Sanofi. It invests in early-stage biotech and digital health companies, from Seed to Series B and beyond.

Sanofi Ventures is a corporate venture arm. It invests directly in companies, from seed to Series C and later, in rare diseases, immunology and inflammation, oncology and cell and gene therapy.

“We invest in top-tier biotech and digital health companies that focus on helping patients and transforming the practice of medicine.”

— Sanofi Ventures, own website
Layer
Direct investor
Type
Corporate venture
Stage
Seed – Series C+
Sectors
Rare diseases, Immunology and inflammation, Oncology, Cell and gene therapy, Vaccines, Digital health and data science

Team, as Sanofi Ventures publishes it

  • Jason P. Hafler Managing Director
  • Laia Crespo Partner
  • Cris De Luca Partner
  • Paulina Hill Partner
  • Christopher Gagliardi Principal
  • Meg Krench Principal
  • Kriti Subramanyam Director of Investments
  • Francesc Dosrius Lleonart Associate Director of Investments
  • Pierre Gaudeaux Associate Director of Investments
  • Rebecca Gorelov Associate Director of Investments

Names and roles exactly as listed on sanofiventures.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 107 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

and 97 more — the graph.

Where this comes from

Every fact above was read from a page Sanofi Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 8761 · added 2026-09-29 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under